Elanco
Large Cap · Healthcare · Drug Manufacturers - Specialty & Generic
$24.42+$0.79 (+3.32%)
Elanco
Large Cap · Healthcare · Drug Manufacturers - Specialty & Generic
$24.42+$0.79 (+3.32%)
Stock analysis
Get the AI take on ELAN
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$13.39
High$27.72
Today $24.42
RSI (14)
34.0Neutral
03070100
Overall score
51/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Current price
$24.42
Lowest
$26
Median target
$31.5
Highest
$34
LowHigh
Operating Record
Revenue
What's working
- Price / sales: You're paying a modest amount for each dollar of revenue coming in.
- Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
What to watch
- Debt exceeds cash by $3.7B, increasing balance-sheet pressure, a warning sign.
- Forward P/E: The price already assumes strong earnings growth that still has to show up.
What the market charges
Forward P/E
Needs attention · 12% above avg
20.11x
Price / sales
Strong · Priced modestly against the revenue it brings in
2.36x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
31.20x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
15.42x
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
3.3%
ROE
Needs attention · Unfavorable
-3.0%
Debt / equity
Favorable · 0.61 - strong leverage
0.64x
Current ratio
Strong · Comfortable room to cover bills due within a year
2.05x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $11.83B | - | +11.9% | 51 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |